齊多夫定雜質(zhì)Ⅱ 司他夫定
|
PCL-#-Chp0118-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
3056-17-5 |
50mg
|
咨詢
|
咨詢 |
PCL |
齊多夫定雜質(zhì)Ⅱ 司他夫定
|
PCL-#-Chp0118-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
3056-17-5 |
25mg
|
咨詢
|
咨詢 |
PCL |
齊多夫定雜質(zhì)Ⅰ 3’-氯-3’-脫氧胸苷
|
PCL-#-Chp0117-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
25526-94-7 |
50mg
|
咨詢
|
咨詢 |
PCL |
齊多夫定雜質(zhì)Ⅰ 3’-氯-3’-脫氧胸苷
|
PCL-#-Chp0117-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
25526-94-7 |
25mg
|
咨詢
|
咨詢 |
PCL |
釓貝葡胺注射液雜質(zhì)Ⅱ4-[2-[雙羧甲基胺]乙基]-2-氧-1-哌嗪乙酸?
|
PCL-#-Chp0116-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0116-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
釓貝葡胺注射液雜質(zhì)Ⅱ4-[2-[雙羧甲基胺]乙基]-2-氧-1-哌嗪乙酸?
|
PCL-#-Chp0116-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0116-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
釓貝葡胺注射液雜質(zhì)Ⅰ(單葡甲銨鹽)[[N-[2-[雙羧甲基胺]乙基]-N-[2-[(羧甲基)乙基]甘氨酸根(4-)]釓(1-)]單葡甲胺
|
PCL-#-Chp0115-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0115-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
釓貝葡胺注射液雜質(zhì)Ⅰ(單葡甲銨鹽)[[N-[2-[雙羧甲基胺]乙基]-N-[2-[(羧甲基)乙基]甘氨酸根(4-)]釓(1-)]單葡甲胺
|
PCL-#-Chp0115-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0115-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
釓貝葡胺注射液雜質(zhì)(游離酸) (±)-4-羧基-5,8,11-三(羧基甲基)-1-苯基-2-氧雜-5,8,11-三氮雜十三烷酸
|
PCL-#-Chp0114-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0114-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
釓貝葡胺注射液雜質(zhì)(游離酸) (±)-4-羧基-5,8,11-三(羧基甲基)-1-苯基-2-氧雜-5,8,11-三氮雜十三烷酸
|
PCL-#-Chp0114-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0114-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
嗎替麥考酚酯雜質(zhì)H 7-羥基-5-甲氧-4-甲基-6-[2-[(2RS)-2-甲基-5-氧代四氫呋喃-2-基]乙基]異苯并呋喃-1(3H)-酮
|
PCL-#-MH02-50mg
|
≥95%,雜質(zhì)對(duì)照品 |
79081-87-1 |
50mg
|
¥ 9000.0
|
現(xiàn)貨 |
PCL |
嗎替麥考酚酯雜質(zhì)H 7-羥基-5-甲氧-4-甲基-6-[2-[(2RS)-2-甲基-5-氧代四氫呋喃-2-基]乙基]異苯并呋喃-1(3H)-酮
|
PCL-#-MH02-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
79081-87-1 |
25mg
|
咨詢
|
咨詢 |
PCL |
嗎替麥考酚酯雜質(zhì)F(麥考酚酸)
|
PCL-#-M374-50mg
|
≥95% ,雜質(zhì)對(duì)照品 |
24280-93-1 |
50mg
|
¥ 600.0
|
3-5天 |
PCL |
嗎替麥考酚酯雜質(zhì)F(麥考酚酸)(E)-6-(4-羥基-6-甲氧基-7-甲基-3-氧代-1,3-二氫異苯并呋喃-5-基)-4-甲基-4-己烯酸
|
PCL-#-M374-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
24280-93-1 |
25mg
|
咨詢
|
咨詢 |
PCL |
嗎替麥考酚酯雜質(zhì)Ⅱ
|
PCL-#-Chp0113-50mg
|
≥95% ,雜質(zhì)對(duì)照品 |
115007-34-6 |
50mg
|
¥ 600.0
|
3-5天 |
PCL |
嗎替麥考酚酯雜質(zhì)Ⅱ:Z-嗎替麥考酚酯(雜質(zhì)C)(Z)-6-(4-羥基-6-甲氧基-7-甲基-3-氧代-1,3-二氫異苯并呋喃-5-基)-4-甲基-4-己稀酸2-(嗎啉-4-基)乙酯
|
PCL-#-Chp0113-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
115007-34-6 |
25mg
|
咨詢
|
咨詢 |
PCL |
嗎替麥考酚酯雜質(zhì)A (4E)-6-(4,6-二羥基-7-甲基-3-氧代-1,3-二氫異苯并呋喃-5-基)-4-甲基-4-己烯酸2-(嗎啉-4-基)乙酯〕
|
PCL-#-MA01-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
1322681-36-6 |
50mg
|
咨詢
|
咨詢 |
PCL |
嗎替麥考酚酯雜質(zhì)A?
|
PCL-#-MA01-25mg
|
≥95% ,雜質(zhì)對(duì)照品 |
1322681-36-6 |
25mg
|
¥ 800.0
|
3-5天 |
PCL |
托吡卡胺雜質(zhì)Ⅰ [N-(4-吡啶甲基)乙胺]
|
PCL-#-Chp0112-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
33403-97-3 |
50mg
|
咨詢
|
咨詢 |
PCL |
托吡卡胺雜質(zhì)Ⅰ [N-(4-吡啶甲基)乙胺]
|
PCL-#-Chp0112-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
33403-97-3 |
25mg
|
咨詢
|
咨詢 |
PCL |
灰黃霉素雜質(zhì)Ⅱ去氫灰黃霉素((1'S)-7氯2'4,6-三甲氧基-6'甲基嫘[苯并呋喃-2(3H),1'[2,5]環(huán)己二烯]-3,4'-二酮)
|
PCL-#-Chp0111-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
3573-90-8 |
50mg
|
咨詢
|
咨詢 |
PCL |
灰黃霉素雜質(zhì)Ⅱ去氫灰黃霉素((1'S)-7氯2'4,6-三甲氧基-6'甲基嫘[苯并呋喃-2(3H),1'[2,5]環(huán)己二烯]-3,4'-二酮)
|
PCL-#-Chp0111-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
3573-90-8 |
25mg
|
咨詢
|
咨詢 |
PCL |
灰黃霉素雜質(zhì)Ⅰ 去氯灰黃霉素((1'S,6'R))-2',4,6-三甲氧基-6'-甲基螺[苯并呋喃-2(3H),1'-[2]環(huán)己烯]-3,4'-二酮)
|
PCL-#-Chp0110-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
3680-32-8 |
50mg
|
咨詢
|
咨詢 |
PCL |
灰黃霉素雜質(zhì)Ⅰ 去氯灰黃霉素((1'S,6'R))-2',4,6-三甲氧基-6'-甲基螺[苯并呋喃-2(3H),1'-[2]環(huán)己烯]-3,4'-二酮)
|
PCL-#-Chp0110-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
3680-32-8 |
25mg
|
咨詢
|
咨詢 |
PCL |